- Article
- Published:
Hypothalamic AMPK and fatty acid metabolism mediate thyroid regulation of energy balance
- Miguel López1,2,3,
- Luis Varela1,2,
- María J Vázquez1,2,
- Sergio Rodríguez-Cuenca3,
- Carmen R González1,2,
- Vidya R Velagapudi4,
- Donald A Morgan5,
- Erik Schoenmakers3,
- Khristofor Agassandian6,
- Ricardo Lage1,2,
- Pablo Blanco Martínez de Morentin1,2,
- Sulay Tovar1,2,
- Rubén Nogueiras1,2,
- David Carling7,
- Christopher Lelliott8,
- Rosalía Gallego9 na1,
- Matej Orešič4 na1,
- Krishna Chatterjee3 na1,
- Asish K Saha10 na1,
- Kamal Rahmouni5,
- Carlos Diéguez1,2 &
- …
- Antonio Vidal-Puig3
Nature Medicinevolume 16, pages1001–1008 (2010)Cite this article
7545Accesses
26Altmetric
Abstract
Thyroid hormones have widespread cellular effects; however it is unclear whether their effects on the central nervous system (CNS) contribute to global energy balance. Here we demonstrate that either whole-body hyperthyroidism or central administration of triiodothyronine (T3) decreases the activity of hypothalamic AMP-activated protein kinase (AMPK), increases sympathetic nervous system (SNS) activity and upregulates thermogenic markers in brown adipose tissue (BAT). Inhibition of the lipogenic pathway in the ventromedial nucleus of the hypothalamus (VMH) prevents CNS-mediated activation of BAT by thyroid hormone and reverses the weight loss associated with hyperthyroidism. Similarly, inhibition of thyroid hormone receptors in the VMH reverses the weight loss associated with hyperthyroidism. This regulatory mechanism depends on AMPK inactivation, as genetic inhibition of this enzyme in the VMH of euthyroid rats induces feeding-independent weight loss and increases expression of thermogenic markers in BAT. These effects are reversed by pharmacological blockade of the SNS. Thus, thyroid hormone–induced modulation of AMPK activity and lipid metabolism in the hypothalamus is a major regulator of whole-body energy homeostasis.
This is a preview of subscription content,access via your institution
Access options
Subscription info for Japanese customers
We have a dedicated website for our Japanese customers. Please go tonatureasia.com to subscribe to this journal.
Prices may be subject to local taxes which are calculated during checkout






Similar content being viewed by others
References
Silva, J.E. Thyroid hormone control of thermogenesis and energy balance.Thyroid5, 481–492 (1995).
Coppola, A. et al. A central thermogenic-like mechanism in feeding regulation: an interplay between arcuate nucleus T3 and UCP2.Cell Metab.5, 21–33 (2007).
Herwig, A., Ross, A.W., Nilaweera, K.N., Morgan, P.J. & Barrett, P. Hypothalamic thyroid hormone in energy balance regulation.Obes. Facts1, 71–79 (2008).
Pijl, H. et al. Food choice in hyperthyroidism: potential influence of the autonomic nervous system and brain serotonin precursor availability.J. Clin. Endocrinol. Metab.86, 5848–5853 (2001).
Cannon, B. & Nedergaard, J. Brown adipose tissue: function and physiological significance.Physiol. Rev.84, 277–359 (2004).
Volpe, J.J. & Kishimoto, Y. Fatty acid synthetase of brain: development, influence of nutritional and hormonal factors and comparison with liver enzyme.J. Neurochem.19, 737–753 (1972).
Gnoni, G.V., Landriscina, C., Ruggiero, F.M. & Quagliariello, E. Effect of hyperthyroidism on lipogenesis in brown adipose tissue of young rats.Biochim. Biophys. Acta751, 271–279 (1983).
Blennemann, B., Leahy, P., Kim, T.S. & Freake, H.C. Tissue-specific regulation of lipogenic mRNAs by thyroid hormone.Mol. Cell. Endocrinol.110, 1–8 (1995).
Cachefo, A. et al. Hepatic lipogenesis and cholesterol synthesis in hyperthyroid patients.J. Clin. Endocrinol. Metab.86, 5353–5357 (2001).
Park, S.H. et al. Effects of thyroid state on AMP-activated protein kinase and acetyl-CoA carboxylase expression in muscle.J. Appl. Physiol.93, 2081–2088 (2002).
Winder, W.W. et al. Long-term regulation of AMP-activated protein kinase and acetyl-CoA carboxylase in skeletal muscle.Biochem. Soc. Trans.31, 182–185 (2003).
Branvold, D.J. et al. Thyroid hormone effects on LKB1, MO25, phospho-AMPK, phospho-CREB and PGC-1α in rat muscle.J. Appl. Physiol.105, 1218–1227 (2008).
Irrcher, I., Walkinshaw, D.R., Sheehan, T.E. & Hood, D.A. Thyroid hormone (T3) rapidly activates p38 and AMPK in skeletal musclein vivo.J. Appl. Physiol.104, 178–185 (2008).
Morini, P., Conserva, A.R., Lippolis, R., Casalino, E. & Landriscina, C. Differential action of thyroid hormones on the activity of certain enzymes in rat kidney and brain.Biochem. Med. Metab. Biol.46, 169–176 (1991).
Blennemann, B., Moon, Y.K. & Freake, H.C. Tissue-specific regulation of fatty acid synthesis by thyroid hormone.Endocrinology130, 637–643 (1992).
Minokoshi, Y. et al. AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus.Nature428, 569–574 (2004).
Gao, S. et al. Leptin activates hypothalamic acetyl-CoA carboxylase to inhibit food intake.Proc. Natl. Acad. Sci. USA104, 17358–17363 (2007).
Kola, B. et al. The orexigenic effect of ghrelin is mediated through central activation of the endogenous cannabinoid system.PLoS One.3, e1797 (2008).
López, M. et al. Hypothalamic fatty acid metabolism mediates the orexigenic action of ghrelin.Cell Metab.7, 389–399 (2008).
Andrews, Z.B. et al. UCP2 mediates ghrelin's action on NPY/AgRP neurons by lowering free radicals.Nature454, 846–851 (2008).
Loftus, T.M. et al. Reduced food intake and body weight in mice treated with fatty acid synthase inhibitors.Science288, 2379–2381 (2000).
Hu, Z., Cha, S.H., Chohnan, S. & Lane, M.D. Hypothalamic malonyl-CoA as a mediator of feeding behavior.Proc. Natl. Acad. Sci. USA100, 12624–12629 (2003).
Obici, S., Feng, Z., Arduini, A., Conti, R. & Rossetti, L. Inhibition of hypothalamic carnitine palmitoyltransferase-1 decreases food intake and glucose production.Nat. Med.9, 756–761 (2003).
Lam, T.K., Schwartz, G.J. & Rossetti, L. Hypothalamic sensing of fatty acids.Nat. Neurosci.8, 579–584 (2005).
Wolfgang, M.J. et al. The brain-specific carnitine palmitoyltransferase-1c regulates energy homeostasis.Proc. Natl. Acad. Sci. USA103, 7282–7287 (2006).
López, M. et al. Tamoxifen-induced anorexia is associated with fatty acid synthase inhibition in the ventromedial nucleus of the hypothalamus and accumulation of malonyl-CoA.Diabetes55, 1327–1336 (2006).
Chakravarthy, M.V. et al. Brain fatty acid synthase activates PPAR-α to maintain energy homeostasis.J. Clin. Invest.117, 2539–2552 (2007).
Lam, T.K. Neuronal regulation of homeostasis by nutrient sensing.Nat. Med.16, 392–395 (2010).
Dulloo, A.G. Biomedicine. A sympathetic defense against obesity.Science297, 780–781 (2002).
Commins, S.P., Watson, P.M., Levin, N., Beiler, R.J. & Gettys, T.W. Central leptin regulates the UCP1 and ob genes in brown and white adipose tissue via different β-adrenoceptor subtypes.J. Biol. Chem.275, 33059–33067 (2000).
Tong, Q. et al. Synaptic glutamate release by ventromedial hypothalamic neurons is part of the neurocircuitry that prevents hypoglycemia.Cell Metab.5, 383–393 (2007).
Chatterjee, V.K. et al. Thyroid hormone resistance syndrome. Inhibition of normal receptor function by mutant thyroid hormone receptors.J. Clin. Invest.87, 1977–1984 (1991).
Lage, R. et al. Ghrelin effects on neuropeptides in the rat hypothalamus depend on fatty acid metabolism actions on BSX but not on gender.FASEB J.24, 2670–2679 (2010).
Hagenfeldt, L., Wennlung, A., Felig, P. & Wahren, J. Turnover and splanchnic metabolism of free fatty acids in hyperthyroid patients.J. Clin. Invest.67, 1672–1677 (1981).
Beylot, M. et al. Lipolytic and ketogenic fluxes in human hyperthyroidism.J. Clin. Endocrinol. Metab.73, 42–49 (1991).
Riis, A.L. et al. Elevated regional lipolysis in hyperthyroidism.J. Clin. Endocrinol. Metab.87, 4747–4753 (2002).
Kahn, B.B., Alquier, T., Carling, D. & Hardie, D.G. AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism.Cell Metab.1, 15–25 (2005).
Lage, R., Diéguez, C., Vidal-Puig, A. & López, M. AMPK: a metabolic gauge regulating whole-body energy homeostasis.Trends Mol. Med.14, 539–549 (2008).
Plum, L. et al. The obesity susceptibility geneCpe links FoxO1 signaling in hypothalamic pro-opiomelanocortin neurons with regulation of food intake.Nat. Med.15, 1195–1201 (2009).
Belgardt, B.F. et al. PDK1 deficiency in POMC-expressing cells reveals FOXO1-dependent and -independent pathways in control of energy homeostasis and stress response.Cell Metab.7, 291–301 (2008).
Pocai, A. et al. Restoration of hypothalamic lipid sensing normalizes energy and glucose homeostasis in overfed rats.J. Clin. Invest.116, 1081–1091 (2006).
He, W., Lam, T.K., Obici, S. & Rossetti, L. Molecular disruption of hypothalamic nutrient sensing induces obesity.Nat. Neurosci.9, 227–233 (2006).
Sangiao-Alvarellos, S. et al. Influence of ghrelin and GH deficiency on AMPK and hypothalamic lipid metabolism.J. Neuroendocrinol.22, 543–556 (2010).
Niijima, A., Rohner-Jeanrenaud, F. & Jeanrenaud, B. Role of ventromedial hypothalamus on sympathetic efferents of brown adipose tissue.Am. J. Physiol.247, R650–R654 (1984).
Holt, S.J., Wheal, H.V. & York, D.A. Hypothalamic control of brown adipose tissue in Zucker lean and obese rats. Effect of electrical stimulation of the ventromedial nucleus and other hypothalamic centres.Brain Res.405, 227–233 (1987).
Halvorson, I., Gregor, L. & Thornhill, J.A. Brown adipose tissue thermogenesis is activated by electrical and chemical (L-glutamate) stimulation of the ventromedial hypothalamic nucleus in cold-acclimated rats.Brain Res.522, 76–82 (1990).
McCrimmon, R.J. et al. Key role for AMP-activated protein kinase in the ventromedial hypothalamus in regulating counterregulatory hormone responses to acute hypoglycemia.Diabetes57, 444–450 (2008).
Nedergaard, J., Bengtsson, T. & Cannon, B. Unexpected evidence for active brown adipose tissue in adult humans.Am. J. Physiol. Endocrinol. Metab.293, E444–E452 (2007).
van Marken Lichtenbelt, W.D. et al. Cold-activated brown adipose tissue in healthy men.N. Engl. J. Med.360, 1500–1508 (2009).
Cypess, A.M. et al. Identification and importance of brown adipose tissue in adult humans.N. Engl. J. Med.360, 1509–1517 (2009).
Virtanen, K.A. et al. Functional brown adipose tissue in healthy adults.N. Engl. J. Med.360, 1518–1525 (2009).
Skarulis, M.C. et al. Thyroid hormone induced brown adipose tissue and amelioration of diabetes in a patient with extreme insulin resistance.J. Clin. Endocrinol. Metab.95, 256–262 (2010).
Viollet, B. et al. The AMP-activated protein kinase alpha2 catalytic subunit controls whole-body insulin sensitivity.J. Clin. Invest.111, 91–98 (2003).
Long, Y.C. & Zierath, J.R. AMP-activated protein kinase signaling in metabolic regulation.J. Clin. Invest.116, 1776–1783 (2006).
Costanzo-Garvey, D.L. et al. KSR2 is an essential regulator of AMP kinase, energy expenditure, and insulin sensitivity.Cell Metab.10, 366–378 (2009).
Dzamko, N. et al. AMPK beta1 deletion reduces appetite, preventing obesity and hepatic insulin resistance.J. Biol. Chem.285, 115–122 (2010).
Rahmouni, K. et al. Hypothalamic PI3K and MAPK differentially mediate regional sympathetic activation to insulin.J. Clin. Invest.114, 652–658 (2004).
Nogueiras, R. et al. Direct control of peripheral lipid deposition by CNS GLP-1 receptor signaling is mediated by the sympathetic nervous system and blunted in diet induced obesity.J. Neurosci.29, 5916–5925 (2009).
Acknowledgements
We thank M. Adams and A. Whittle for discussion and editing and L. Casas, M. Portas and K. Burling for excellent technical assistance. This work has been supported by grants from the UK Medical Research Council (A.V.-P.: G0802051), the Wellcome Trust (K.C.: 080237; A.V.-P.: 065326/Z/01/Z), Xunta de Galicia (R.G.: PGIDITPXIB20811PR), Fondo Investigaciones Sanitarias (M.L.: PS09/01880), Ministerio de Ciencia e Innovación (C.D.: BFU2008; M.L.: RyC-2007-00211; R.N.: RyC-2008-02219 and SAF2009-07049), the EU (A.V.-P. and M.O.: FP7MITIN; A.V.-P. and M.O.: LSHM-CT-2005–018734; C.D., M.L. and R.N.: Health-F2-2008-223713; M.L.: Marie Curie Program QLK6-CT-2002-51671) and the US National Institutes of Health (A.K.S.: DK-19514 and DK-67509; K.R.: HL-084207). CIBER de Fisiopatología de la Obesidad y Nutrición is an initiative of Instituto de Salud Carlos III (ISCIII).
Author information
Rosalía Gallego, Matej Orešič, Krishna Chatterjee and Asish K Saha: These authors contributed equally to this work.
Authors and Affiliations
Department of Physiology, School of Medicine, University of Santiago de Compostela-Instituto de Investigación Sanitaria, Santiago de Compostela (A Coruña), Spain.,
Miguel López, Luis Varela, María J Vázquez, Carmen R González, Ricardo Lage, Pablo Blanco Martínez de Morentin, Sulay Tovar, Rubén Nogueiras & Carlos Diéguez
Centro de Investigación Biomédica en Red de la Fisiopatología de la Obesidad y Nutrición (CIBERobn) (A Coruña), Spain
Miguel López, Luis Varela, María J Vázquez, Carmen R González, Ricardo Lage, Pablo Blanco Martínez de Morentin, Sulay Tovar, Rubén Nogueiras & Carlos Diéguez
Institute of Metabolic Science, Metabolic Research Laboratories, Addenbrooke's Hospital, University of Cambridge, Cambridge, UK
Miguel López, Sergio Rodríguez-Cuenca, Erik Schoenmakers, Krishna Chatterjee & Antonio Vidal-Puig
Technical Research Centre of Finland (VTT), Espoo, Finland
Vidya R Velagapudi & Matej Orešič
Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, Iowa, USA
Donald A Morgan & Kamal Rahmouni
Department of Anatomy and Cell Biology, University of Iowa Carver College of Medicine, Iowa City, Iowa, USA
Khristofor Agassandian
Cellular Stress Group, Medical Research Council Clinical Sciences Centre, Hammersmith Hospital, Imperial College, London, UK
David Carling
Department of Biosciences, AstraZeneca, Research and Development, Mölndal, Sweden
Christopher Lelliott
Department of Morphological Sciences, School of Medicine, University of Santiago de Compostela (A Coruña), Spain.,
Rosalía Gallego
Diabetes Research Unit, Boston Medical Center, Boston, Massachusetts, USA
Asish K Saha
- Miguel López
You can also search for this author inPubMed Google Scholar
- Luis Varela
You can also search for this author inPubMed Google Scholar
- María J Vázquez
You can also search for this author inPubMed Google Scholar
- Sergio Rodríguez-Cuenca
You can also search for this author inPubMed Google Scholar
- Carmen R González
You can also search for this author inPubMed Google Scholar
- Vidya R Velagapudi
You can also search for this author inPubMed Google Scholar
- Donald A Morgan
You can also search for this author inPubMed Google Scholar
- Erik Schoenmakers
You can also search for this author inPubMed Google Scholar
- Khristofor Agassandian
You can also search for this author inPubMed Google Scholar
- Ricardo Lage
You can also search for this author inPubMed Google Scholar
- Pablo Blanco Martínez de Morentin
You can also search for this author inPubMed Google Scholar
- Sulay Tovar
You can also search for this author inPubMed Google Scholar
- Rubén Nogueiras
You can also search for this author inPubMed Google Scholar
- David Carling
You can also search for this author inPubMed Google Scholar
- Christopher Lelliott
You can also search for this author inPubMed Google Scholar
- Rosalía Gallego
You can also search for this author inPubMed Google Scholar
- Matej Orešič
You can also search for this author inPubMed Google Scholar
- Krishna Chatterjee
You can also search for this author inPubMed Google Scholar
- Asish K Saha
You can also search for this author inPubMed Google Scholar
- Kamal Rahmouni
You can also search for this author inPubMed Google Scholar
- Carlos Diéguez
You can also search for this author inPubMed Google Scholar
- Antonio Vidal-Puig
You can also search for this author inPubMed Google Scholar
Contributions
M.L., L.V., M.J.V., S.R.-C., C.R.G., R.L., P.B.M.d.M., S.T. and R.N. performed thein vivo experiments, analytical methods (real-time RT-PCR,in situ hybridization, western blotting and enzymatic assays) and collected and analyzed the data. V.R.V. and M.O. developed analytical platforms and performed and analyzed lipidomic experiments. D.A.M., K.A. and K.R. performed and analyzed the sympathetic nerve activity recording studies. D.C. developed AMPK-DN– and AMPK-CA–encoding adenoviruses. E.S. and K.C. generated TR-DN constructs and validated the TR-DN–encoding adenoviruses. R.G. developed and performed immunohistochemistry and immunofluorescence experiments. A.K.S. developed and performed metabolic analyses. M.L., L.V., S.R.-C., C.L., K.C., K.R., C.D. and A.V.-P. designed the experiments. M.L., S.R.-C., R.N., C.L., K.C., K.R., C.D. and A.V.-P. discussed the manuscript. M.L., C.D. and A.V.-P. coordinated and directed the project. M.L. and A.V.-P. developed the hypothesis and wrote the manuscript.
Corresponding authors
Correspondence toMiguel López orAntonio Vidal-Puig.
Ethics declarations
Competing interests
C.L. is an employee of AstraZeneca Research and Development and holds stock in AstraZeneca Research and Development.
Supplementary information
Supplementary Text and Figures
Supplementary Table 1, Supplementary Figures 1–7 and Supplementary Methods (PDF 2357 kb)
Rights and permissions
About this article
Cite this article
López, M., Varela, L., Vázquez, M.et al. Hypothalamic AMPK and fatty acid metabolism mediate thyroid regulation of energy balance.Nat Med16, 1001–1008 (2010). https://doi.org/10.1038/nm.2207
Received:
Accepted:
Published:
Issue Date:
Share this article
Anyone you share the following link with will be able to read this content:
Sorry, a shareable link is not currently available for this article.
Provided by the Springer Nature SharedIt content-sharing initiative